Mike has developed expertise across a range of therapeutic areas in his decade-long career in the life science commercialization space. This has involved leading a range of engagements with a diverse set of life science companies spanning products, franchises, and therapeutic areas. Mike has developed a particular focus in oncology and rare disease. He has extensive experience in the vaccine space in both commercial vaccines and stockpiled and pandemic vaccines. Mike has also developed a particular expertise in product planning and portfolio strategy as well as launch readiness, commercialization strategy, and diligence support.
Prior to joining ClearView, Mike completed a Ph.D. in Biochemistry from Wake Forest University. After receiving his doctorate, Mike completed a postdoctoral fellowship with the NIH in DNA mismatch repair and has extensive commercialization experience from his time leading sales and marketing in the U.S. and Canada with a life science instrumentation manufacturer.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson